Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial

Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial

The FAME 3 subgroup analysis demonstrated that in patients with three-vessel coronary artery disease, women had a higher 3-year risk of major adverse cardiac and cerebrovascular events (MACCE; all-cause death, myocardial infarction [MI], stroke, and repeat revascularization) after coronary artery bypass grafting (CABG) than men. In women, there was no difference in 3-year MACCE risk between those who underwent fractional flow reserve (FFR)-guided PCI and those who underwent CABG, whereas in men, outcomes were better with CABG, Dr. Kuniaki Takahashi and colleagues, Stanford University, USA, reported in the January 27 issue of JACC: Cardiovascular Interventions.

The FAME 3 trial randomized 1,500 patients with three-vessel coronary artery disease to either an FF...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
This website is automatically translated using Google Translate.